News

PharmiWeb57s
Drägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years
Half Year Report/Half Year ResultsDrägerwerk AG & Co. KGaA: Dräger with strong order intake in the first half of 2025 – Highest demand in five years 29.07.2025 / 07:30 CET/CESTThe issuer is solely ...
PharmiWeb5m
Relief Therapeutics Announces Proposed Business Combination with NeuroX, successor to MindMaze
Mergers & Acquisitions29-Jul-2025 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics ...
PharmiWeb36m
Lobe Sciences Ltd. Engages ArcStone Securities for Strategic Capital Markets Advisory
VANCOUVER, BC / ACCESS Newswire / July 29, 2025 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F), a biopharmaceutical company focused on developing therapeutics for rare and underserved ...
PharmiWeb36m
Lobe Sciences Announces $341,425 CAD Private Placement for General Corporate Purposes
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / July 29, 2025 / Lobe Sciences Ltd. ("Lobe Sciences" ...